In healthy states, skeletal muscle efficiently responds to insulin to promote glucose uptake and utilization; however, in T2DM, this regulatory mechanism is disrupted—chronic low-grade inflammation reduces skeletal muscle insulin sensitivity (11), impairing glucose transport and phosphorylation (12), which exacerbates hyperglycemia. The gene discussed is INS; the disease is type 2 diabetes mellitus.